Your browser doesn't support javascript.
Genome-wide association study of COVID-19 severity among the Chinese population.
Li, Yuanfeng; Ke, Yuehua; Xia, Xinyi; Wang, Yahui; Cheng, Fanjun; Liu, Xinyi; Jin, Xin; Li, Boan; Xie, Chengyong; Liu, Siyang; Chen, Weijun; Yang, Chenning; Niu, Yuguang; Jia, Ruizhong; Chen, Yong; Liu, Xiong; Wang, Zhihua; Zheng, Fang; Jin, Yan; Li, Zhen; Yang, Ning; Cao, Pengbo; Chen, Hongxia; Ping, Jie; He, Fuchu; Wang, Changjun; Zhou, Gangqiao.
  • Li Y; State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.
  • Ke Y; Center for Disease Control and Prevention of PLA, Beijing, China.
  • Xia X; Department of Laboratory Medicine, Wuhan Huoshenshan Hospital, Wuhan, Hubei, China.
  • Wang Y; Department of Laboratory Medicine, Wuhan Huoshenshan Hospital, Wuhan, Hubei, China.
  • Cheng F; COVID-19 Research Center, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing Clinical College of Southern Medical University, Nanjing, Jiangsu, China.
  • Liu X; State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.
  • Jin X; State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Lifeomics, Beijing, China.
  • Li B; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Xie C; State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.
  • Liu S; School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
  • Chen W; Clinical Laboratory Medicine Center, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Yang C; Medical College of Guizhou University, Guiyang, Guizhou, China.
  • Niu Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong, China.
  • Jia R; University of Chinese Academy of Sciences, Beijing, China.
  • Chen Y; State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.
  • Liu X; Department of Otolaryngology, The First Medical Center of General Hospital of PLA, Beijing, China.
  • Wang Z; Center for Disease Control and Prevention of PLA, Beijing, China.
  • Zheng F; Center for Disease Control and Prevention of PLA, Beijing, China.
  • Jin Y; Center for Disease Control and Prevention of PLA, Beijing, China.
  • Li Z; Center for Disease Control and Prevention of PLA, Beijing, China.
  • Yang N; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Cao P; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Chen H; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Ping J; Clinical Laboratory Medicine Center, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • He F; State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.
  • Wang C; State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.
  • Zhou G; State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.
Cell Discov ; 7(1): 76, 2021 Aug 31.
Article in English | MEDLINE | ID: covidwho-1380898
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes a broad clinical spectrum of coronavirus disease 2019 (COVID-19). The development of COVID-19 may be the result of a complex interaction between the microbial, environmental, and host genetic components. To reveal genetic determinants of susceptibility to COVID-19 severity in the Chinese population, we performed a genome-wide association study on 885 severe or critical COVID-19 patients (cases) and 546 mild or moderate patients (controls) from two hospitals, Huoshenshan and Union hospitals at Wuhan city in China. We identified two loci on chromosome 11q23.3 and 11q14.2, which are significantly associated with the COVID-19 severity in the meta-analyses of the two cohorts (index rs1712779 odds ratio [OR] = 0.49; 95% confidence interval [CI], 0.38-0.63 for T allele; P = 1.38 × 10-8; and index rs10831496 OR = 1.66; 95% CI, 1.38-1.98 for A allele; P = 4.04 × 10-8, respectively). The results for rs1712779 were validated in other two small COVID-19 cohorts in the Asian populations (P = 0.029 and 0.031, respectively). Furthermore, we identified significant eQTL associations for REXO2, C11orf71, NNMT, and CADM1 at 11q23.3, and CTSC at 11q14.2, respectively. In conclusion, our findings highlight two loci at 11q23.3 and 11q14.2 conferring susceptibility to the severity of COVID-19, which might provide novel insights into the pathogenesis and clinical treatment of this disease.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study / Reviews Language: English Journal: Cell Discov Year: 2021 Document Type: Article Affiliation country: S41421-021-00318-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study / Reviews Language: English Journal: Cell Discov Year: 2021 Document Type: Article Affiliation country: S41421-021-00318-6